About
CatAI's remote patient monitoring solution is based on a highly accurate and reliable technology that enables tracking medical parameters in the comfort of a patient's home. It is ideally suited for hospitals and clinics, nursing homes, and assisted living facilities, to which it is offered as a SaaS-based solution.
Our Proudacts:
1. Remote Patient Monitoring (RPM): For Hospitals, Home care and hospitalization Companies, Chronic diseases management, Elderly people Facilities. Our AI platform enables remote patient monitoring by capturing vital signs through any device, such as a tablet or smartphone. The system automatically processes and sends the data to healthcare providers' dashboards, allowing for continuous monitoring and quick response to any abnormalities. This technology can significantly reduce staff workload and operational costs, ensuring better patient care with easy setup regardless of the medical device.
2. Early Detection of Oral Cancer: For Cancer Centers,clinics or insurance companies. Our ORALYZE system utilizes mobile phone imaging to detect early signs of oral cancer - 96%. We conducted research that was published in the prestigious journal Cancers. The research was conducted in collaboration with the North of Israel Hospital, Israeli Ministry of Health and IBM.This innovative approach allows for rapid, accurate, and accessible screening, which can be crucial in improving patient outcomes by diagnosing cancer at its initial stages.
Q&A
- What is CatAI's primary focus?
- CatAI focuses on AI-enhanced personal health care monitoring, offering solutions for remote patient monitoring and early detection of oral cancer.
- What is CatAI's Remote Patient Monitoring (RPM) solution?
- CatAI's RPM solution is an AI platform that enables remote patient monitoring by capturing vital signs through devices like tablets or smartphones. The system processes and sends data to healthcare providers' dashboards for continuous monitoring, aiming to reduce staff workload and operational costs.
- What is CatAI's ORALYZE system?
- CatAI's ORALYZE system utilizes mobile phone imaging to detect early signs of oral cancer with a reported 96% accuracy. This system is designed for cancer centers, clinics, or insurance companies.
- When was CatAI founded?
- CatAI was founded in October 2021.
- In which sector does CatAI primarily operate?
- CatAI operates primarily in the Health Tech & Life Sciences sector, with specializations in Digital Healthcare and Patient Remote Monitoring.
- What business models does CatAI utilize?
- CatAI utilizes B2G, B2B2C, and B2B business models.
- Has CatAI published any research related to its technology?
- Yes, CatAI conducted research on its ORALYZE system for early detection of oral cancer, which was published in the journal Cancers. This research was a collaboration with the North of Israel Hospital, the Israeli Ministry of Health, and IBM.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | catai.io |
|---|---|
| linkedin.com/company/80069911 |
Identifiers & details
| Founded | 2021-10 |
|---|---|
| Employees (exact) | 6 |
Radar intelligence
Patents
| EPO | 20 |
|---|
Publications (Crossref)
| Works | 2 |
|---|
Web history (Wayback)
| Domain | catai.io |
|---|
Certificate / subdomain footprint
| Subdomains | 10 |
|---|